ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

ADVFN

Trade Now

EasyMarkets
Market Data
News
Tools
Markets
Discover
Subscribe Login/Register Profile Icon
S&P 500
4,594.63
(
0.59%
)
US Tech 100
15,629.20
(
0.49%
)
Dow Jones
36,245.50
(
0.82%
)
Brent Oil
79.525
(
-0.11%
)
Bitcoin
40,098.24
(
0.28%
)
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. NGM Biopharmaceuticals Inc (NGM)

  7. NGM Biopharmaceuticals Inc (NGM) News

NGM NGM Biopharmaceuticals Inc

0.74
-0.0069 (-0.92%)
Dec 01 2023 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
NGM Biopharmaceuticals Inc NGM NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
Upgrade Icon
-0.0069 -0.92% 0.74 19:15:12
Open Price Low Price High Price Close Price Prev Close
0.7306 0.7224 0.769999 0.7694 0.7469
more quote information »

Recent News

Date Time Source Heading
11/13/202309:45GLOBENGM Bio Presents Positive Phase 2b Results from the ALPINE 4..
11/08/202318:13EDGAR2Form 3 - Initial statement of beneficial ownership of..
11/08/202318:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/08/202318:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/08/202318:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/07/202316:05GLOBENGM Bio to Participate in Upcoming Investor Conferences
11/02/202316:12EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/02/202316:06EDGAR2Form 8-K - Current report
11/02/202316:01GLOBENGM Bio Reports Third Quarter 2023 Financial Results and..
10/17/202317:28EDGAR2Form 8-K - Current report
10/11/202316:05GLOBENGM Bio Announces Oral Plenary Presentation of Data from..
9/27/202308:30PRNUSAlexandria Real Estate Equities, Inc.'s One-of-a-Kind,..
9/11/202316:01EDGAR2Form 8-K/A - Current report: [Amend]
8/11/202316:08EDGAR2Form 8-K - Current report
8/07/202300:15EDGAR2Form EFFECT - Notice of Effectiveness
8/04/202317:01EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
8/04/202316:01EDGAR2Form S-3/A - Registration statement under Securities Act of..
8/03/202316:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/03/202316:07EDGAR2Form 8-K - Current report
8/03/202316:01GLOBENGM Bio Reports Second Quarter 2023 Financial Results and..
5/25/202309:00GLOBENGM Bio to Participate in Upcoming Investor Conferences
5/08/202316:05GLOBENGM Bio Announces Presentation of Data from Phase 2..
5/04/202316:05GLOBENGM Bio Reports First Quarter 2023 Financial Results and..
3/01/202309:00GLOBENGM Bio to Participate in the Cowen 43rd Annual Health Care..
2/28/202316:05GLOBENGM Bio Provides Business Highlights and Reports Fourth..
1/12/202308:00GLOBENGM Bio to Participate in the B. Riley Securities 3rd Annual..
1/09/202309:00GLOBENGM Bio Outlines Corporate Strategy and Provides Guidance on..
12/12/202219:00GLOBENGM Bio Gives Presentation Featuring Preclinical..
12/09/202210:10TRMNAnalysts Are Bullish on These Healthcare Stocks: NGM..
12/07/202218:45GLOBENGM Bio Presents Preliminary Data from Phase 1 Monotherapy..

Your Recent History

NASDAQ
NGM
NGM Biopharmaceuticals
Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com